ADS · CUSIP 07782B104 · who reports it, how much, and how much it matters to them
23 of the 720 hedge fund managers we track reported shares of Belite Bio, Inc (Nasdaq: BLTE) on Form 13F for 30 June 2026. Between them they reported USD 403m. The largest position belongs to RTW Investments, at USD 110m. The manager with the most riding on it is Verdad Advisers, where it is 2.0% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | RTW Investments2 funds on PPLI.com | USD 110m | 0.9% |
| 2 | Millennium Management6 funds on PPLI.com | USD 76m | 0.0% |
| 3 | Maverick Capital20 funds on PPLI.com | USD 61m | 0.5% |
| 4 | Holocene Advisors2 funds on PPLI.com | USD 39m | 0.1% |
| 5 | Logos Global Management1 fund on PPLI.com | USD 38m | 1.7% |
| 6 | Citadel Advisors32 funds on PPLI.com | USD 29m | 0.0% |
| 7 | Renaissance Technologies13 funds on PPLI.com | USD 8.6m | 0.0% |
| 8 | POINT72 Asset Management17 funds on PPLI.com | USD 7.9m | 0.0% |
| 9 | Two Sigma Investments35 funds on PPLI.com | USD 5.9m | 0.0% |
| 10 | PFM Health Sciences3 funds on PPLI.com | USD 5.4m | 0.5% |
| 11 | Walleye Capital8 funds on PPLI.com | USD 4.9m | 0.0% |
| 12 | Artia Global Partners1 fund on PPLI.com | USD 3.8m | 0.7% |
| 13 | Verdad Advisers6 funds on PPLI.com | USD 2.1m | 2.0% |
| 14 | Orbimed Advisors1 fund on PPLI.com | USD 2m | 0.0% |
| 15 | Boothbay Fund Management2 funds on PPLI.com | USD 2m | 0.0% |
| 16 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.5m | 0.0% |
| 17 | HighVista Strategies27 funds on PPLI.com | USD 1.5m | 0.3% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 1.4m | 0.0% |
| 19 | Capricorn Fund Managers8 funds on PPLI.com | USD 986,000 | 0.1% |
| 20 | Voleon Capital Management13 funds on PPLI.com | USD 968,000 | 0.0% |
| 21 | Engineers Gate Manager1 fund on PPLI.com | USD 427,000 | 0.0% |
| 22 | Jain Global1 fund on PPLI.com | USD 324,000 | 0.0% |
| 23 | Bayforest Capital1 fund on PPLI.com | USD 47,273 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Verdad Advisers | USD 2.1m | 2.0% |
| 2 | Logos Global Management | USD 38m | 1.7% |
| 3 | RTW Investments | USD 110m | 0.9% |
| 4 | Artia Global Partners | USD 3.8m | 0.7% |
| 5 | Maverick Capital | USD 61m | 0.5% |
| 6 | PFM Health Sciences | USD 5.4m | 0.5% |
| 7 | HighVista Strategies | USD 1.5m | 0.3% |
| 8 | Holocene Advisors | USD 39m | 0.1% |
| 9 | Capricorn Fund Managers | USD 986,000 | 0.1% |
| 10 | Bayforest Capital | USD 47,273 | 0.0% |
Belite Bio, Inc trades under the symbol BLTE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 07782B104.
23 of the 720 hedge fund managers PPLI.com tracks reported Belite Bio, Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 110m), Millennium Management (USD 76m), Maverick Capital (USD 61m), Holocene Advisors (USD 39m) and Logos Global Management (USD 38m).
23 managers in our coverage reported it, and between them they run 397 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Verdad Advisers, where the position was 2.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Belite Bio, Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.